India’s Pharmaceutical Market Analyzed
India’s drug industry is booming. Experts predict it will grow to nearly $130 billion by 2030 – that’s double what it is now. This growth shows how important and advanced the industry is becoming.
Key Points
- India’s pharma market will reach $130 billion by 2030.
- Pharmaceutical exports hit $30.47 billion in 2024-25, up 9.4%.
- India is the world’s #3 producer by volume and #14 by value.
- Over 3,000 companies manufacture drugs across 60 therapeutic areas.
- Exports reach 200 markets, with strong regulatory destinations included.
- US & Europe account for over 53% of India’s pharmaceutical sales.
Market Size and Growth
The current value of India’s pharmaceutical market is around $60 billion. This incredible expansion signifies the industry’s increasing sophistication and its significant role in global healthcare. The projected growth demonstrates a strong and sustainable future for Indian pharmaceutical companies.
Export Performance
India’s pharmaceutical exports jumped to $30.47 billion in the last financial year – a significant rise of 9.4%. This growth is thanks to India’s ability to make a lot of medicines and its expanding reach into new countries. Strong manufacturing combined with successful international sales drive this growth.
Global Ranking and Production
India currently ranks as the world’s third-largest producer of medicine by volume and the fourteenth by value. A large number of companies – over 3,000 – operate across a wide range of medical categories. This vast network of production highlights India’s commitment to meeting global demand.
Market Reach and Trade
Indian medicines are sold in over 200 countries worldwide. A large proportion of these exports – over 60% – go to countries with strict regulations about medicine quality and safety. The United States is the biggest buyer (34%), followed closely by Europe (19%).
Investing in India’s pharmaceutical sector represents a strategic opportunity for global healthcare advancement.
